Literature DB >> 28912272

The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells.

Makiko Tsuboi1, Keisuke Taniuchi2,3, Takahiro Shimizu4, Motoaki Saito4, Toshiji Saibara1,3.   

Abstract

HOX genes encode transcription factors that function as sequence-specific transcription factors that are involved in cellular proliferation, differentiation, and death. The aim of this study was to investigate the role of a HOX family protein, HOXB7, in the motility and invasiveness of pancreatic cancer cells. We previously identified a HOXB7 transcript that is one of a number of transcripts that are preferentially translated in membrane protrusions in pancreatic cancer cells. Immunocytochemistry showed that HOXB7 was localized to the cell protrusions of migrating pancreatic cancer cells. Knockdown of HOXB7 by transfection with HOXB7-specific siRNA decreased these protrusions and inhibited the motility and invasiveness of the cells. Transfection of a HOXB7-rescue construct into the HOXB7-knockdown cells restored peripheral actin structures in cell protrusions and abrogated the HOXB7 knockdown-induced decrease in cell protrusions. It is generally accepted that the Rho family of GTPases regulate the organization of actin filaments and contribute to the formation of cell protrusions. The levels of the active Rho GTPases were not influenced by HOXB7 in the cells; however, HOXB7 knockdown decreased the level of phosphorylated ERK1/2. This inactivation of ERK1/2 decreased cell protrusions, thereby inhibiting the invasiveness of pancreatic cancer cells. Further investigation showed that HOXB7/ERK1/2 signaling selectively stimulated JNK and HSP27 phosphorylation and thereby increased the motility and invasiveness of pancreatic cancer cells. These results suggested that HOXB7 stimulates ERK1/2 phosphorylation and provided evidence that HOXB7, besides its role in transcriptional regulation, also promotes cell motility and invasiveness.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cell invasion; cell motility; cell protrusions; extracellular-signal-regulated kinase (ERK); homeobox; pancreatic cancer

Mesh:

Substances:

Year:  2017        PMID: 28912272      PMCID: PMC5663872          DOI: 10.1074/jbc.M116.772780

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Rho GTPases.

Authors:  D J Mackay; A Hall
Journal:  J Biol Chem       Date:  1998-08-14       Impact factor: 5.157

Review 2.  Signal transduction through MAP kinase cascades.

Authors:  T S Lewis; P S Shapiro; N G Ahn
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

3.  BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1.

Authors:  Keisuke Taniuchi; Kunihiko Yokotani; Toshiji Saibara
Journal:  Neoplasia       Date:  2012-05       Impact factor: 5.715

4.  Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP.

Authors:  Keisuke Taniuchi; Isao Nishimori; Michael A Hollingsworth
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

5.  AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation.

Authors:  Ryan F L O'Shaughnessy; Jonathan C Welti; James C Cooke; Ariel A Avilion; Bobby Monks; Morris J Birnbaum; Carolyn Byrne
Journal:  J Biol Chem       Date:  2007-04-17       Impact factor: 5.157

6.  Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation.

Authors:  A Paz; R Haklai; G Elad-Sfadia; E Ballan; Y Kloog
Journal:  Oncogene       Date:  2001-11-08       Impact factor: 9.867

7.  MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.

Authors:  Michele T Yip-Schneider; C Max Schmidt
Journal:  Pancreas       Date:  2003-11       Impact factor: 3.327

8.  Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis.

Authors:  Hexin Chen; Ji Shin Lee; Xiaohui Liang; Huiping Zhang; Tao Zhu; Zhe Zhang; M Evangeline Taylor; Cynthia Zahnow; Lionel Feigenbaum; Alan Rein; Saraswati Sukumar
Journal:  Cancer Res       Date:  2008-05-07       Impact factor: 12.701

Review 9.  Mammalian Rho GTPases: new insights into their functions from in vivo studies.

Authors:  Sarah J Heasman; Anne J Ridley
Journal:  Nat Rev Mol Cell Biol       Date:  2008-09       Impact factor: 94.444

10.  Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients.

Authors:  Rui Zhang; Shangen Zheng; Yuwen Du; Yuanyuan Wang; Wenqiao Zang; Guoqiang Zhao
Journal:  Diagn Pathol       Date:  2014-03-18       Impact factor: 2.644

View more
  9 in total

1.  The prognostic value of homeobox B7 expression in patients with hepatocellular carcinoma.

Authors:  Yarong Guo; Xiaojiang Qin; Bao Chai; Junmei Jia; Jiahong Yi; Kang Wang; Xiaomin Hou
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

Review 2.  Multiple roles of HOX proteins in Metastasis: Let me count the ways.

Authors:  Joy Jonkers; Priya Pai; Saraswati Sukumar
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

3.  CircRNA hsa_circ_0070934 functions as a competitive endogenous RNA to regulate HOXB7 expression by sponging miR‑1236‑3p in cutaneous squamous cell carcinoma.

Authors:  Da-Wei Zhang; Hai-Yan Wu; Chuan-Rong Zhu; Dong-Dong Wu
Journal:  Int J Oncol       Date:  2020-05-14       Impact factor: 5.650

4.  Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma.

Authors:  PengYu Yang; Wei Kang; YaWen Pan; XianJun Zhao; Lei Duan
Journal:  Cancer Manag Res       Date:  2019-09-03       Impact factor: 3.989

5.  Oncogenic and tumor suppressor function of MEIS and associated factors.

Authors:  Birkan Gİrgİn; Medine KaradaĞ-Alpaslan; Fatih KocabaŞ
Journal:  Turk J Biol       Date:  2020-12-14

Review 6.  Molecular implications of HOX genes targeting multiple signaling pathways in cancer.

Authors:  U Sangeetha Shenoy; Divya Adiga; Shama Prasada Kabekkodu; Keith D Hunter; Raghu Radhakrishnan
Journal:  Cell Biol Toxicol       Date:  2021-10-06       Impact factor: 6.691

Review 7.  Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer.

Authors:  Richard Morgan; Keith Hunter; Hardev S Pandha
Journal:  Int J Cancer       Date:  2022-02-15       Impact factor: 7.316

Review 8.  HOX Genes Family and Cancer: A Novel Role for Homeobox B9 in the Resistance to Anti-Angiogenic Therapies.

Authors:  Serena Contarelli; Vita Fedele; Davide Melisi
Journal:  Cancers (Basel)       Date:  2020-11-08       Impact factor: 6.639

9.  HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma.

Authors:  Xiang Wu; Jin Li; Tingyuan Yan; Xueping Ke; Xin Li; Yumin Zhu; Jianrong Yang; Zhongwu Li
Journal:  Cancer Cell Int       Date:  2021-07-24       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.